24/7 Patient Assistance: 760-405-8205

Approximately 50% of patients who received treatment with Gefitinib experienced partial remission for an average period of 6 months.

U N C O M M O N   side effects
  • interstitial lung disease, liver damage,
  • gastrointestinal perforation, severe diarrhea,
  • ocular disorders

Gefitinib

(Lung Cancer)

Gefitinib is taken orally once a day
with or without food.

C O M M O N   side effects
  • diarrhea, rash,
  • acne, dry skin,
  • pruritus